119: Bio-Reactor or Bio-Rocket? Scaling Up with Arsenale Bio's Massimo Portincaso

Karl and Erum sit down with Massimo Portincaso, founder of Arsenale BioYards, to discuss the urgent need to rethink how we scale biomanufacturing. Massimo shares why today’s approach to industrial biotech—modeled after biopharma—is fundamentally flawed and how Arsenale is flipping the script. From nature co-design to AI-driven strain selection, he lays out a bold vision for scaling bio-based production in a way that is economically viable and industrially scalable. If you care about the future of precision fermentation, sustainable materials, and the bioeconomy, this is a conversation you don’t want to miss!

Learn more at www.messaginglab.com/groweverything

Links and Resources:

• Arsenale Bioyards

• Farm.One

• Common Side Effects (TV series)

• Nature Co-Design report

• Genomatica aka Geno

• Officinae Bio (now Maravai Life Sciences)

• "Scaling Cells, Dreaming Big: The Biomanufacturing Cloud with Synonym’s Edward Shenderovich" 

Topics Covered: 

Biomanufacturing, bioreactors, downstream processing, upstream processing, bioengineering, bioeconomy, italian biotech 

Have a question or comment? Message us here:

Text or Call (804) 505-5553

Instagram  / Twitter / LinkedIn / Youtube / Grow Everything

Email: groweverything@messaginglab.com

Music by: Nihilore

Production by: Amplafy Media